How Much Does GLP-1 Weight Loss Treatment Cost in Hong Kong?

→ For a complete overview, see our Complete Guide to GLP-1 Weight Loss in Hong Kong.

Monthly Medication Costs

Prices vary depending on the medication, dosage, and pharmacy. These are approximate ranges in Hong Kong as of 2026:

Medication	Starting Dose Cost/Month	Maintenance Dose Cost/Month
Ozempic (semaglutide injection)	HK$1,200–1,800	HK$1,800–3,000
Rybelsus (semaglutide oral)	HK$1,000–1,500	HK$1,500–2,500
Mounjaro (tirzepatide injection)	HK$1,500–2,000	HK$2,500–4,000
Saxenda (liraglutide injection)	HK$1,500–2,000	HK$2,000–3,500

Note: You start at a lower dose and increase gradually over 4–16 weeks, so initial monthly costs are lower than maintenance-phase costs.

Total Treatment Cost: What to Budget

GLP-1 treatment is not a one-month affair. Effective weight management typically requires 12–18 months of continuous treatment(Based on clinical guidelines and prescribing information). Here's a realistic cost projection:

12-Month Estimated Total Cost (HKD)

Medication	Low Estimate	High Estimate
Ozempic	HK$18,000	HK$36,000
Rybelsus	HK$14,000	HK$28,000
Mounjaro	HK$25,000	HK$45,000
Saxenda	HK$20,000	HK$40,000

These figures include medication costs only and do not include consultation fees.

Consultation and Service Fees

Private Clinic (In-Person)

• Initial consultation: HK$500–1,500
• Follow-up consultations: HK$300–800 each
• Blood tests: HK$500–2,000 (depending on panel)

noah™ (Online)

noah™ offers an integrated service where consultation fees are bundled transparently: - Online doctor consultation included with subscription - No hidden clinic fees - Medication delivered to your door - Regular follow-up included in the treatment plan

Does Insurance Cover GLP-1 Medications?

Short answer: Usually not for weight management.

• Hospital Authority (HA): GLP-1 medications are available through HA for type 2 diabetes management but are not routinely prescribed for weight loss alone(Based on clinical guidelines and prescribing information)
• Private medical insurance: Most plans in Hong Kong exclude weight-management medications from coverage. Some may cover GLP-1 medications if prescribed for diabetes with documented medical necessity(Based on clinical guidelines and prescribing information)
• Corporate wellness plans: A small but growing number of corporate plans are beginning to include obesity treatment(Based on clinical guidelines and prescribing information)

Recommendation: Contact your insurer directly with the specific medication name and indication to confirm coverage.

Cost vs Value: The Economic Case

While GLP-1 medication represents a significant investment, consider the alternative costs of untreated obesity:

• Chronic disease management: Hypertension, diabetes, and cardiovascular medications can cost HK$500–3,000+ per month indefinitely(Based on clinical guidelines and prescribing information)
• Bariatric surgery in HK: HK$80,000–200,000+ for the procedure alone, plus potential complications and follow-up(Based on clinical guidelines and prescribing information)
• Lost productivity: Obesity-related health issues contribute to absenteeism and reduced work capacity(Based on clinical guidelines and prescribing information)
• Quality of life: The physical and mental health burden of obesity affects every aspect of daily life

A 12-month course of GLP-1 medication costing HK$20,000–45,000 may prevent or reduce decades of chronic disease management costs.

How to Reduce Your Costs

1. Start with Rybelsus — The oral formulation is generally the most affordable option, suitable for patients comfortable with modest weight-loss goals
2. Use noah™'s transparent pricing — No surprise consultation fees or markups
3. Commit to lifestyle changes — Better diet and exercise can amplify medication effects, potentially allowing lower doses or shorter treatment duration
4. Ask about step-down plans — Your doctor can create a plan to reduce dose once your target weight is reached, lowering ongoing costs
5. Check for employer benefits — Some Hong Kong employers offer health and wellness allowances that can be applied to treatment

noah™ Pricing

noah™ is committed to transparent, competitive pricing for GLP-1 treatment in Hong Kong. Our plans include: - Licensed doctor consultation - Personalised treatment plan - Medication at competitive prices - Discreet delivery across Hong Kong - Ongoing follow-up and dose adjustments

Visit the noah™ website for current pricing and treatment plan options.

Frequently Asked Questions

1. Why are GLP-1 medications so expensive in Hong Kong?

GLP-1 medications are patented biologics (or complex peptides) that require sophisticated manufacturing. Hong Kong does not regulate private medication prices, and demand currently exceeds supply in many markets(Based on clinical guidelines and prescribing information).

2. Will prices come down?

Potentially. As more GLP-1 medications enter the market and patents expire, competition may drive prices lower. Biosimilar semaglutide products are in development(Based on clinical guidelines and prescribing information).

3. Is it cheaper to buy GLP-1 medication from overseas?

Importing prescription medications for personal use involves regulatory and safety risks. Counterfeit GLP-1 medications have been identified in unregulated supply chains(Based on clinical guidelines and prescribing information). We strongly recommend obtaining medication from a licensed Hong Kong pharmacy.

4. Can I pay in instalments?

noah™ offers monthly treatment plans, so you pay as you go rather than committing to a large upfront sum.

5. What if I can't afford the more expensive options?

Discuss budget with your noah™ doctor. Rybelsus and liraglutide are more affordable options that still deliver clinically meaningful weight loss. Your doctor can recommend the best medication within your budget.

References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185
2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. PMID: 35658024
3. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. PMID: 26132939

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any medication. Treatment suitability is determined by your prescribing doctor based on your individual health profile.

© 2026 noah™. All rights reserved.